Suppressing obesity and over-secretion of insulin with 2-(.alpha

Details Suppressing obesity and over-secretion of insulin with 2-(.alpha Suppressing obesity and over-secretion of insulin with 2-(.alpha

1980-08-18

1982-09-14

Schwartz, Richard A.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

260239A, A61K 31395, C07D20504

Patent

active

043495478

ABSTRACT:
2-(.alpha.-hydroxy-m-trifluoromethylbenzyl)azetidine and its physiologically acceptable acid addition salts have antiobesity action as well as suppressive action against oversecretion of insulin.

REFERENCES:
Chemical Abstracts, 89:117,867s, (1978), [German Ols 2,653,407, 6/1/78, Gold et al.].
Chemical Abstracts, 82:55495p, (1975), [Schade, D., et al., Diabetes, 1974, 23(8), 657-661].
March, J., Advanced Organic Chemistry, McGraw Hill, New York, 1968, p. 684.
Derwent Abstract 40579A/23 of German Pat. No. DT2653-407.

Affiliated with

Also associated with

Rating

Suppressing obesity and over-secretion of insulin with 2-(.alpha does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppressing obesity and over-secretion of insulin with 2-(.alpha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppressing obesity and over-secretion of insulin with 2-(.alpha will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2154797